Who is sponsoring NCT05540171?

NCT05540171 is sponsored by Aminu Kano Teaching Hospital.

What drugs are being tested in NCT05540171?

Interventions in NCT05540171: Oral health education and instructions/training for self-oral care.

What condition does NCT05540171 study?

NCT05540171 studies HIV, Dental Caries, Quality of Life, Oral Disease, Oral Infection, Oral Manifestations.

Is NCT05540171 still recruiting?

NCT05540171 is currently completed. Last updated 7 March 2024.

Last reviewed 2024-03-07 · How we verify

NCT05540171

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

An Educational Intervention Program to Improve the Oral Health of HIV-Positive Children in Kano, Nigeria.

Completed NA Last updated 7 March 2024

What this trial tests

NA trial testing Oral health education and instructions/training for self-oral care in HIV in 172 participants. Completed in 15 September 2023.

Timeline

22 December 2022

Primary endpoint
15 September 2023

15 September 2023

Quick facts

Lead sponsor	Aminu Kano Teaching Hospital
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	supportive care
Enrollment	172
Start date	22 December 2022
Primary completion	15 September 2023
Estimated completion	15 September 2023
Sites	1 location across Nigeria

Drugs / interventions tested

Oral health education and instructions/training for self-oral care

Conditions studied

HIV — all drugs for HIV →
Dental Caries — all drugs for Dental Caries →
Quality of Life — all drugs for Quality of Life →
Oral Disease — all drugs for Oral Disease →

Sponsor

Aminu Kano Teaching Hospital

Who can join

Adults 8 to 16, any sex, with HIV or Dental Caries. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this 2- arm randomized-control study is to determine the effect of an oral hygiene self care intervention on the oral health status and oral health-related quality of life (OHRQoL) of HIV-positive children (age: 8-16 years, n=172) presenting to five pediatric HIV clinics in Kano, Nigeria. The intervention will comprise oral health education and instructions on oral self-care. Data on oral health status and OHRQoL will be obtained at baseline and at 1, 3 and 6 months. Study findings will help inform policies to improve the oral health and OHRQoL of HIV-positive Nigerian children and guide the integration of oral health care services into HIV programs.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

A 2-arm randomized controlled study to improve the oral health of children living with HIV in Nigeria: Protocol and study design.
Adeyemo YI, Aliyu MH, Folayan MO, Coker MO, et al · · 2024 · cited 1× · PMID 38404532 · DOI 10.1016/j.cct.2023.107375

Verify or expand the search:

Other recruiting trials for HIV

Currently open trials in the same condition.

NCT06705478 — Pramipexole Versus Escitalopram to Treat Major Depressive Disorder (MDD) and Comorbid MDD With Mild Neurocognitive Disor · Phase 2 · recruiting
NCT07221214 — GLP-1 Receptor Agonists to Decrease Ethanol and CVD Risk in HIV · Phase 2 · recruiting
NCT07226128 — The Effects of Cognitive Behavioral Therapy on Insulin Resistance in People With HIV · NA · recruiting
NCT07390474 — Clinical Trial to Evaluate the Safety and Immunogenicity of the V2 Apex-Directed Immunogens DV201P-RNA and DV202B1-RNA i · Phase 1 · recruiting
NCT07390955 — A Study of Safety and Drug Levels of ePGT121v1-LS, PGDM1400LS, and VRC07-523LS in Adult Participants Without HIV-1 · Phase 1 · recruiting

Other Aminu Kano Teaching Hospital trials

Trials by the same sponsor.

NCT03081949 — Peripartum Cardiomyopathy in Nigeria Registry · Phase 4 · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05540171 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Aminu Kano Teaching Hospital
Last refreshed: 7 March 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05540171.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing